{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T06:31:41Z","timestamp":1759991501654},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1097\/jgp.0b013e3181e89a46","type":"journal-article","created":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T06:49:12Z","timestamp":1278658152000},"page":"423-429","source":"Crossref","is-referenced-by-count":10,"title":["The Relationship of Cardiovascular Risk Factors to Alzheimer Disease in Choctaw Indians"],"prefix":"10.1016","volume":"19","author":[{"given":"Myron F.","family":"Weiner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Hynan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle B.","family":"Womack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger N.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Hua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Xi","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/JGP.0b013e3181e89a46_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0891988706286505","article-title":"Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease","volume":"19","author":"Bhargava","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1469-1809.1999.6340301.x","article-title":"Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a \u2018thrifty\u2019 allele?","volume":"63","author":"Corbo","year":"1999","journal-title":"Ann Hum Genet"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib3","series-title":"NIH Publication 01\u20133285","author":"Strong Heart Data Book","year":"2001"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib4","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1001\/archinte.165.18.2098","article-title":"Racial disparities in hypertension prevalence, awareness, and management","volume":"165","author":"Hertz","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/oxfordjournals.aje.a115134","article-title":"Methods and prevalence of noninsulin-dependent diabetes mellitus in a biethnic Colorado population. San Luis Valley Diabetes Study","volume":"129","author":"Hamman","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0304-3940(02)00150-7","article-title":"Apolipoprotein E4 and tau allele frequencies among Choctaw Indians","volume":"324","author":"Henderson","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archneur.1996.00550100071017","article-title":"Genetic factors for the development of Alzheimer's Disease in the Cherokee Indian","volume":"53","author":"Rosenberg","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/ana.20694","article-title":"APOE epsilon 4 is not associated with Alzheimer's disease in elderly Nigerians","volume":"59","author":"Gureje","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1041610293001358","article-title":"Alzheimer's disease is rare in Cree","volume":"5","author":"Hendrie","year":"1993","journal-title":"Int Psychogeriatr"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1212\/WNL.57.6.1089","article-title":"Cholesterol and Alzheimer's disease. Is there a link?","volume":"57","author":"Simons","year":"2001","journal-title":"Neurology"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib11","first-page":"217224","article-title":"Do statins reduce risk of incident dementia and Alzheimer disease?","volume":"62","author":"Zandi","year":"2005","journal-title":"The Cache County Study Arch Gen Psychiatry"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000026149","article-title":"Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease","volume":"17","author":"Notkola","year":"1998","journal-title":"Neuroepidemiology"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1212\/WNL.54.1.240","article-title":"Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans","volume":"54","author":"Evans","year":"2000","journal-title":"Neurology"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib15","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","article-title":"Vitamin status and intake as primary determinants of homocysteinemia in an elderly population","volume":"270","author":"Selhub","year":"1993","journal-title":"JAMA"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"46","author":"Seshadri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib17","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu- Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0895-7061(01)02146-X","article-title":"Hypertension treatment patterns in American Indians: The Strong Heart Study","volume":"14","author":"Hayslett","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/WAD.0b013e318169d701","article-title":"Atherosclerosis risk factors in American Indians with Alzheimer's Disease","volume":"22","author":"Weiner","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib20","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's Disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib22","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1001\/jama.1993.03500180078038","article-title":"Population-based norms for the Mini-Mental State Examination by age and educational level","volume":"269","author":"Crum","year":"1993","journal-title":"JAMA"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib23","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/156720509787313952","article-title":"Brain MRI, apolipoprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controls","volume":"6","author":"Weiner","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0378-4347(91)80407-4","article-title":"Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum","volume":"565","author":"Ubbink","year":"1991","journal-title":"J Chromatogr"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib25","series-title":"Biostatistical Analysis","first-page":"223","year":"1999"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0006-3223(98)00222-4","article-title":"Apolipoprotein Ee4, other risk factors, and course of Alzheimer's disease","volume":"45","author":"Weiner","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ng0194-29","article-title":"Genetic associations with human longevity at the APOE and ACE loci","volume":"6","author":"Sch\u00e4cter","year":"1994","journal-title":"Nat Genet"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","article-title":"Facts and recommendations about total homocysteine determinations: an expert opinion","volume":"50","author":"Refsum","year":"2004","journal-title":"Clin Chem"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/107424840300800403","article-title":"Elevated levels of plasma homocysteine in hypertensive patients with diabetes mellitus","volume":"8","author":"Qureshi","year":"2003","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib30","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/ATVBAHA.108.162743","article-title":"Homocysteine or renal impairment: which is the real cardiovascular risk factor?","volume":"28","author":"Potter","year":"2008","journal-title":"Arteriosclerosis Thromb Vasc Biol"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1874473710801010047","article-title":"Alterations in homocysteine metabolism among alcohol dependent patients-clinical, pathobiochemical and genetic aspects","volume":"1","author":"Lutz","year":"2008","journal-title":"Curr Drug Abuse Rev"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib32","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archpsyc.65.11.1286","article-title":"Homocysteine and depression in later life","volume":"65","author":"Almeida","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gps.2317","article-title":"Associations between stroke risk and cognition in normal aging and Alzheimer's disease with and without depression","volume":"25","author":"Bangen","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib34","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/WAD.0b013e318188e80d","article-title":"Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with Alzheimer disease","volume":"22","author":"Goldstein","year":"2000","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1097\/JGP.0b013e3181e89a46_bib35","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","article-title":"High-dose B Vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial","volume":"300","author":"Aisen","year":"2008","journal-title":"JAMA"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112600463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112600463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T18:54:33Z","timestamp":1559242473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748112600463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1064748112600463"],"URL":"https:\/\/doi.org\/10.1097\/jgp.0b013e3181e89a46","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}